AnGes (FRA:AJW) Cyclically Adjusted PS Ratio: (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:AJW AnGes Inc FRA:AJW
51 GF Score
Price €0.22
GF Value €0.22
! 5 Warning Signs
View Full Analysis

What is AnGes Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation

AnGes  (FRA:AJW) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

AnGes Cyclically Adjusted PS Ratio Related Terms

AnGes Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for AnGes's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnGes Cyclically Adjusted PS Ratio Chart

AnGes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.71 17.97 13.13 13.77 18.45

AnGes Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.90 23.86 18.45 17.92 0.00

FRA:AJW vs VRTX, REGN, RVMD: Cyclically Adjusted PS Ratio Comparison

For the Biotechnology subindustry, AnGes's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AnGes Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnGes's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AnGes's Cyclically Adjusted PS Ratio falls into.


FRA:AJW
51GF Score
AnGes Inc FRA:AJW
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnGes Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AnGes's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, AnGes's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/113.6000*113.6000
=0.000

Current CPI (Jun. 2026) = 113.6000.

AnGes Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.011 98.000 0.013
201612 0.030 98.400 0.035
201703 0.010 98.100 0.012
201706 0.009 98.500 0.010
201709 0.008 98.800 0.009
201712 0.010 99.400 0.011
201803 0.007 99.200 0.008
201806 0.009 99.200 0.010
201809 0.008 99.900 0.009
201812 0.027 99.700 0.031
201903 0.006 99.700 0.007
201906 0.007 99.800 0.008
201909 0.012 100.100 0.014
201912 0.000 100.500 0.000
202003 0.000 100.300 0.000
202006 0.001 99.900 0.001
202009 0.001 99.900 0.001
202012 0.001 99.300 0.001
202103 0.001 99.900 0.001
202106 0.001 99.500 0.001
202109 0.001 100.100 0.001
202112 0.001 100.100 0.001
202203 0.001 101.100 0.001
202206 0.001 101.800 0.001
202209 0.001 103.100 0.001
202212 0.001 104.100 0.001
202303 0.001 104.400 0.001
202306 0.001 105.200 0.001
202309 0.002 106.200 0.002
202312 0.002 106.800 0.002
202403 0.003 107.200 0.003
202406 0.006 108.200 0.006
202409 0.004 108.900 0.004
202412 0.005 110.700 0.005
202503 0.003 111.100 0.003
202506 0.004 111.700 0.004
202509 0.004 112.000 0.004
202512 0.004 113.000 0.004
202603 0.003 112.700 0.003
202606 0.000 113.600 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AnGes (FRA:AJW) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be overvalued. The current stock price of €0.22 is trading 0.9% above its estimated GF Value™ of €0.22.

Key valuation signals for FRA:AJW:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €0.22 vs. price of €0.22 (0.9% above fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the FRA:AJW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AnGes Business Description

Other Exchanges 4563:JapanAJW:Germany
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
51GF Score

Get the complete analysis for FRA:AJW

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.22
Price
€0.22
GF Value